Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.9 |
mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |